IL160882A0 - Method for treating hepatitis c virus infection in treatment failure patients - Google Patents

Method for treating hepatitis c virus infection in treatment failure patients

Info

Publication number: IL160882A0
Authority: IL; Israel
Prior art keywords: virus infection; treating hepatitis; failure patients; treatment failure; hepatitis
Prior art date: 2001-09-28

Application number

IL16088202A

Other languages

English (en)

Original Assignee

Intermune Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-28

Filing date

2002-09-20

Publication date

2004-08-31

2002-09-20 Application filed by Intermune Inc filed Critical Intermune Inc

2004-08-31 Publication of IL160882A0 publication Critical patent/IL160882A0/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Zoology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IL16088202A 2001-09-28 2002-09-20 Method for treating hepatitis c virus infection in treatment failure patients IL160882A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US32610001P	2001-09-28	2001-09-28
PCT/US2002/030006 WO2003028754A1 (en)	2001-09-28	2002-09-20	Method for treating hepatitis c virus infection in treatment failure patients

Publications (1)

Publication Number	Publication Date
IL160882A0 true IL160882A0 (en)	2004-08-31

Family

ID=23270817

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL16088202A IL160882A0 (en)	2001-09-28	2002-09-20	Method for treating hepatitis c virus infection in treatment failure patients

Country Status (14)

Country	Link
US (2)	US20050031585A1 (es)
EP (1)	EP1435997A4 (es)
JP (1)	JP2005508926A (es)
KR (1)	KR20040037191A (es)
CN (1)	CN1561227A (es)
AR (1)	AR036698A1 (es)
BR (1)	BR0212928A (es)
CA (1)	CA2461596A1 (es)
HU (1)	HUP0401659A3 (es)
IL (1)	IL160882A0 (es)
MX (1)	MXPA04002915A (es)
NO (1)	NO20041685L (es)
WO (1)	WO2003028754A1 (es)
ZA (1)	ZA200402231B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20100316608A1 (en) *	2009-06-15	2010-12-16	Vijayaprakash Suppiah	Method of Determining A Response To Treatment With Immunomodulatory Composition
MX339762B (es)	2011-09-28	2016-05-27	Univ Autonoma Del Estado De Morelos	Metalopeptidos inmunomoduladores (immp) y composiciones que los contienen.
CA2811250C (en)	2011-10-21	2015-08-11	Abbvie Inc.	Methods for treating hcv
SE1450019A1 (sv)	2011-10-21	2014-01-10	Abbvie Inc	Förfaranden för att behandla HCV innefattande minst två direktverkande antivirala agenser, ribavirin men inte interferon
US8466159B2 (en)	2011-10-21	2013-06-18	Abbvie Inc.	Methods for treating HCV
US8492386B2 (en)	2011-10-21	2013-07-23	Abbvie Inc.	Methods for treating HCV
EP3448392A4 (en)	2016-04-28	2020-01-15	Emory University	ALKYNOUS THERAPEUTIC NUCLEOTIDE AND NUCLEOSIDE COMPOSITIONS AND RELATED APPLICATIONS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5372808A (en) *	1990-10-17	1994-12-13	Amgen Inc.	Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
US5980884A (en) *	1996-02-05	1999-11-09	Amgen, Inc.	Methods for retreatment of patients afflicted with Hepatitis C using consensus interferon
US6172046B1 (en) *	1997-09-21	2001-01-09	Schering Corporation	Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection
US6127046A (en) *	1997-12-04	2000-10-03	Cummins Engine Company, Inc.	Formation of a graphite-free surface in a ferrous material to produce an improved intermetallic bond

2002
- 2002-09-20 BR BR0212928-0A patent/BR0212928A/pt not_active IP Right Cessation
- 2002-09-20 US US10/490,456 patent/US20050031585A1/en not_active Abandoned
- 2002-09-20 MX MXPA04002915A patent/MXPA04002915A/es unknown
- 2002-09-20 EP EP02761770A patent/EP1435997A4/en not_active Withdrawn
- 2002-09-20 CA CA002461596A patent/CA2461596A1/en not_active Abandoned
- 2002-09-20 IL IL16088202A patent/IL160882A0/xx unknown
- 2002-09-20 WO PCT/US2002/030006 patent/WO2003028754A1/en not_active Ceased
- 2002-09-20 CN CNA028191072A patent/CN1561227A/zh active Pending
- 2002-09-20 KR KR10-2004-7004603A patent/KR20040037191A/ko not_active Withdrawn
- 2002-09-20 HU HU0401659A patent/HUP0401659A3/hu unknown
- 2002-09-20 JP JP2003532084A patent/JP2005508926A/ja active Pending
- 2002-09-27 AR ARP020103667A patent/AR036698A1/es unknown
2004
- 2004-03-19 ZA ZA200402231A patent/ZA200402231B/en unknown
- 2004-04-27 NO NO20041685A patent/NO20041685L/no not_active Application Discontinuation
2008
- 2008-02-20 US US12/034,542 patent/US20080213218A1/en not_active Abandoned

Also Published As

Publication number	Publication date
BR0212928A (pt)	2004-10-13
US20080213218A1 (en)	2008-09-04
JP2005508926A (ja)	2005-04-07
CN1561227A (zh)	2005-01-05
NO20041685L (no)	2004-06-23
HUP0401659A2 (hu)	2004-11-29
WO2003028754A1 (en)	2003-04-10
AR036698A1 (es)	2004-09-29
EP1435997A4 (en)	2006-03-01
MXPA04002915A (es)	2004-07-05
KR20040037191A (ko)	2004-05-04
CA2461596A1 (en)	2003-04-10
ZA200402231B (en)	2005-03-22
US20050031585A1 (en)	2005-02-10
EP1435997A1 (en)	2004-07-14
HUP0401659A3 (en)	2005-02-28

Similar Documents

Publication	Publication Date	Title
IL174796A0 (en)	2009-02-11	Methods for treating viral infection using-il-28 and il-29
IL164729A0 (en)	2005-12-18	Nucleoside derivatives for treating hepatitis c virus infection
PL376043A1 (en)	2005-12-12	Nucleoside derivatives for treating hepatitis c virus infection
IL160278A0 (en)	2004-07-25	System and method for face and body treatment
IL155887A0 (en)	2003-12-23	Improved hemodialysis treatment apparatus and method
AU2002346686A1 (en)	2003-06-23	Compositions and method for treating hepatitis virus infection
IL160881A0 (en)	2004-08-31	Method for treating hepatitis c virus infection in treatment failure patients
IL157251A0 (en)	2004-02-19	Hepatitis b virus treatment
AU2003274537A1 (en)	2004-05-04	Pyrrolidine derivatives for use in treating heaptitis c virus infection
IL162236A0 (en)	2005-11-20	Purified hepatitis c virus envelopeproteins for dagnostic and therapeutic use
IL160882A0 (en)	2004-08-31	Method for treating hepatitis c virus infection in treatment failure patients
EP1525216A4 (en)	2009-07-08	COMBINATION THERAPY FOR THE TREATMENT OF HIV INFECTION
AU2002324753A1 (en)	2003-07-09	Composition and method for treating viral infection
AU2002365168A8 (en)	2003-07-30	Method and composition for treating and preventing hiv infection and aids
ZA200502307B (en)	2005-11-30	Method for treating patients with massive blood loss
AU2003254129A8 (en)	2004-02-09	Method and composition for treating and preventing hepatitis b infection and symptoms thereof
EP1581149A4 (en)	2006-07-19	METHOD OF TREATING PATIENTS FOR EXPOSURE TO RADIATION
AU2002327531A1 (en)	2003-03-10	Therapeutic compositions and methods for treating viral infection
AU2001277055A1 (en)	2002-01-30	Composition for treatment of and method of monitoring hepatitis c virus using interferon-tau
AU2003256678A8 (en)	2004-03-03	Method and composition for treating and preventing hepatitis c infection
AU2003259198A8 (en)	2004-02-09	Method and composition for treating and preventing influenza infection and symptoms thereof
AU2003299493A8 (en)	2004-05-13	Compositions and methods for the treatment of hepatitis c virus infection
HU0000207D0 (en)	2000-03-28	Composition and method for treating sclerotinia infection
AU2003254089A8 (en)	2004-02-09	Method and composition for treating and preventing herpesvirus infection
AU2003259514A8 (en)	2004-03-19	Apparatus and method for treating infectious diseases